510(k) K130470

BD MAX CDIFF ASSAY, BD MAX INSTRUMENT by Geneohm Sciences Canada, Inc. (Bd Diagnostics) — Product Code OZN

K130470 is an FDA 510(k) premarket notification submitted by Geneohm Sciences Canada, Inc. (Bd Diagnostics) for the device "BD MAX CDIFF ASSAY, BD MAX INSTRUMENT". The FDA issued a decision of Substantially Equivalent on Apr 2, 2013. The device falls under product code OZN (C. Difficile Toxin Gene Amplification Assay), a Class II device regulated under 21 CFR 866.3130. Geneohm Sciences Canada, Inc. (Bd Diagnostics) has 3 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 2, 2013
Date Received
Feb 25, 2013
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
C. Difficile Toxin Gene Amplification Assay
Device Class
Class II
Regulation Number
866.3130
Review Panel
MI
Submission Type
510(k)

Amplification assay for the detection of c. Difficile toxin genes from stool specimens of symptomatic patients.

Need the full FDA record for Geneohm Sciences Canada, Inc. (Bd Diagnostics)? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K130470. Report a data issue: hello@regdatalab.com.